Our Research

Our publications

1. MC Fesler, MC Sanow, DL Mantle, GE Trobough, N Nasseri-Nik, RB Stricker. Chronic Histiocytic Intervillositis Successful Treatment of Recurrent Miscarriage with Anticoagulation and Immunotherapy. ASRI 2021 (POSTER)

2. Reed JL, Winger EE. IVIg therapy increases delivery birthweight in babies born to women with elevated preconception proportion of peripheral blood (CD56+/CD3-) natural killer cells. Clin Exp Obstet Gynecol. 2017;44(3):384-391.

3. Winger EE, Reed JL, Ji X. First Trimester Pbmc Microrna Predicts Adverse Pregnancy Outcome. Am J Reprod Immunol. 2014 Jun 28. doi: 10.1111/aji.12287. 

4. Winger EE, Reed JL, Ashoush S, El-Toukhy T, Taranissi M. Die-Off Ratio Correlates with Increased TNF-á:IL-10 Ratio and Decreased IVF Success Rates Correctable with Humira. Am J Reprod Immunol. 2012 Jul 30. doi: 10.1111/j.1600-0897.2012.01179.x.

5. Virro M, Winger EE, Reed JL. Intravenous Immunoglobulin for Repeated IVF Failure and Unexplained Infertility. Am J Reprod Immunol. 2012 Jul 17. doi: 10.1111/j.1600-0897.2012.01169.x. 

6. Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M. Elevated Preconception CD56(+) 16(+) and/or Th1:Th2 Levels Predict Benefit from IVIG Therapy in Subfertile Women Undergoing IVF. Am J Reprod Immunol. 2011 May 30. doi: 10.1111/j.1600-0897.2011.01018.x.

7. Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M. Birth Defect Rates in Women Using Adalimumab (Humira(®) ) to Treat Immunologic-Based Infertility in IVF Patients. Am J Reprod Immunol. 2011 Apr 19. doi: 10.1111/j.1600-0897.2011.00994.x. 

8. Winger EE, Reed JL. Low Circulating CD4(+)CD25(+)Foxp3(+) T Regulatory Cell Levels Predict Miscarriage Risk in Newly Pregnant Women with a History of Failure. Am J Reprod Immunol. 2011 Feb 14. doi: 10.1111/j.1600-0897.2011.00992.x.

9. Winger EE , Reed JL, Ashoush S, Ahuja S , El-Toukhy T, Taranissi M: Degree of TNF-a/IL-10 Cytokine Elevation Correlates With IVF Success Rates in Women Undergoing Treatment With Adalimumab (Humira) and IVIG. Am J Reprod Immunol. 2011

10. Winger EE, Reed JL:A retrospective analysis of fondaparinux versus enoxaparin treatment in women with infertility or pregnancy loss. Am J Reprod Immunol 2009 Oct;62(4):253-60. Epub 2009 Aug 24.

11. Winger EE, Reed JL, Ashoush S, Sapna A, El-Toukhy T, Taranissi M: “Treatment with adalimumab (Humira) and intravenous immunoglobulin (IVIG) improves pregnancy rates in women undergoing IVF. American Journal of Reproductive Immunology, 2009; 61:113-120.

12. Winger EE, Reed JL. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol. 2008 Jul;60(1):8-16.

13. Winger EE, Reed JL, Stricker RB: Los Gatos, USA Lymphocyte Immunization Therapy (LIT) Combined with Intravenous Immunoglobulin (IVIG) Improves Live Birth Rates in Women with Primary Recurrent Spontaneous Abortion (RSA) European Conference for Reproductive Immunology, Berlin, Germany, Sept 2 2007.

14. Stricker RB, Winger EE. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin. Am J Reprod Immunol. 2005 Dec;54(6):390-6.

15. Stricker RB, Steinleitner A, Winger EE: Intravenous immunoglogulin (IVIG) therapy for immunologic abortion. Clinical and Applied Immunology Reviews 2 (2002) 187-199. Free full text article: Click here.

16. Stricker RB, Steinleitner A, Bookoff CN, Weckstein LN, Winger EE. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin. Fertil Steril. 2000 Mar;73(3):536-40.


Also see:


Additional Research Resources:

American Journal of Reproductive Immunology

Journal of Reproductive Immunology